Artículos de revistas sobre el tema "Protein-HIV Virus"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Protein-HIV Virus".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Travis, J. "HIV Protein Prepares Virus' Next Victims". Science News 152, n.º 4 (26 de julio de 1997): 53. http://dx.doi.org/10.2307/3981058.
Texto completoRomani, Bizhan y Susan Engelbrecht. "Human immunodeficiency virus type 1 Vpr: functions and molecular interactions". Journal of General Virology 90, n.º 8 (1 de agosto de 2009): 1795–805. http://dx.doi.org/10.1099/vir.0.011726-0.
Texto completoÁlvarez, Enrique, Alfredo Castelló, Luis Menéndez-Arias y Luis Carrasco. "HIV protease cleaves poly(A)-binding protein". Biochemical Journal 396, n.º 2 (15 de mayo de 2006): 219–26. http://dx.doi.org/10.1042/bj20060108.
Texto completoLiu, Hongmei, Xiaoyun Wu, Hongling Xiao y John C. Kappes. "Targeting Human Immunodeficiency Virus (HIV) Type 2 Integrase Protein into HIV Type 1". Journal of Virology 73, n.º 10 (1 de octubre de 1999): 8831–36. http://dx.doi.org/10.1128/jvi.73.10.8831-8836.1999.
Texto completoElalouf, Amir. "In-silico Structural Modeling of Human Immunodeficiency Virus Proteins". Biomedical Engineering and Computational Biology 14 (enero de 2023): 117959722311544. http://dx.doi.org/10.1177/11795972231154402.
Texto completoCoghlan, Andy. "Virus-sabotaging protein may help people defy HIV". New Scientist 220, n.º 2940 (octubre de 2013): 19. http://dx.doi.org/10.1016/s0262-4079(13)62520-8.
Texto completoTang, Yao, Ulrike Winkler, Eric O. Freed, Ted A. Torrey, Wankee Kim, Henry Li, Stephen P. Goff y Herbert C. Morse. "Cellular Motor Protein KIF-4 Associates with Retroviral Gag". Journal of Virology 73, n.º 12 (1 de diciembre de 1999): 10508–13. http://dx.doi.org/10.1128/jvi.73.12.10508-10513.1999.
Texto completoNoble, Beth, Paolo Abada, Juan Nunez-Iglesias y Paula M. Cannon. "Recruitment of the Adaptor Protein 2 Complex by the Human Immunodeficiency Virus Type 2 Envelope Protein Is Necessary for High Levels of Virus Release". Journal of Virology 80, n.º 6 (15 de marzo de 2006): 2924–32. http://dx.doi.org/10.1128/jvi.80.6.2924-2932.2006.
Texto completoFackler, Oliver T., Paola d'Aloja, Andreas S. Baur, Maurizio Federico y B. Matija Peterlin. "Nef from Human Immunodeficiency Virus Type 1F12 Inhibits Viral Production and Infectivity". Journal of Virology 75, n.º 14 (15 de julio de 2001): 6601–8. http://dx.doi.org/10.1128/jvi.75.14.6601-6608.2001.
Texto completoMeschi, Joseph, Erika C. Crouch, Paul Skolnik, Khabirah Yahya, Uffe Holmskov, Rikke Leth-Larsen, Ida Tornoe, Tesfaldet Tecle, Mitchell R. White y Kevan L. Hartshorn. "Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication". Journal of General Virology 86, n.º 11 (1 de noviembre de 2005): 3097–107. http://dx.doi.org/10.1099/vir.0.80764-0.
Texto completoVillet, Stéphanie, Baya Amel Bouzar, Thierry Morin, Gérard Verdier, Catherine Legras y Yahia Chebloune. "Maedi-Visna Virus and Caprine Arthritis Encephalitis Virus Genomes Encode a Vpr-Like but No Tat Protein". Journal of Virology 77, n.º 17 (1 de septiembre de 2003): 9632–38. http://dx.doi.org/10.1128/jvi.77.17.9632-9638.2003.
Texto completoConti, Lucia, Barbara Varano, M. Cristina Gauzzi, Paola Matarrese, Maurizio Federico, Walter Malorni, Filippo Belardelli y Sandra Gessani. "Impairment of Human Immunodeficiency Virus Type 1 (HIV-1) Entry into Jurkat T Cells by Constitutive Expression of the HIV-1 Vpr Protein: Role of CD4 Down-Modulation". Journal of Virology 74, n.º 21 (1 de noviembre de 2000): 10207–11. http://dx.doi.org/10.1128/jvi.74.21.10207-10211.2000.
Texto completoAbada, Paolo, Beth Noble y Paula M. Cannon. "Functional Domains within the Human Immunodeficiency Virus Type 2 Envelope Protein Required To Enhance Virus Production". Journal of Virology 79, n.º 6 (15 de marzo de 2005): 3627–38. http://dx.doi.org/10.1128/jvi.79.6.3627-3638.2005.
Texto completoChan, Eric Y., Jennifer N. Sutton, Jon M. Jacobs, Andrey Bondarenko, Richard D. Smith y Michael G. Katze. "Dynamic Host Energetics and Cytoskeletal Proteomes in Human Immunodeficiency Virus Type 1-Infected Human Primary CD4 Cells: Analysis by Multiplexed Label-Free Mass Spectrometry". Journal of Virology 83, n.º 18 (8 de julio de 2009): 9283–95. http://dx.doi.org/10.1128/jvi.00814-09.
Texto completoWang, Bao-Zhong, Weimin Liu, Sang-Moo Kang, Munir Alam, Chunzi Huang, Ling Ye, Yuliang Sun et al. "Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like Particles". Journal of Virology 81, n.º 20 (1 de agosto de 2007): 10869–78. http://dx.doi.org/10.1128/jvi.00542-07.
Texto completoAlatortseva, G. I., M. N. Nosik, L. N. Nesterenko, I. I. Amiantova, V. V. Dotsenko, L. N. Luhverchik, M. V. Zhuckina, V. U. Kabargina, E. N. Kudryavtseva y V. V. Zverev. "Study of Antigenic properties of Human immunodeficiency Virus NEF protein Recombinant Analog". Epidemiology and Vaccine Prevention 15, n.º 3 (20 de junio de 2016): 83–93. http://dx.doi.org/10.31631/2073-3046-2016-15-3-83-93.
Texto completoGriffin, Stephen D. C., Jane F. Allen y Andrew M. L. Lever. "The Major Human Immunodeficiency Virus Type 2 (HIV-2) Packaging Signal Is Present on All HIV-2 RNA Species: Cotranslational RNA Encapsidation and Limitation of Gag Protein Confer Specificity". Journal of Virology 75, n.º 24 (15 de diciembre de 2001): 12058–69. http://dx.doi.org/10.1128/jvi.75.24.12058-12069.2001.
Texto completoChazal, Nathalie, Gregory Singer, Christopher Aiken, Marie-Louise Hammarskjöld y David Rekosh. "Human Immunodeficiency Virus Type 1 Particles Pseudotyped with Envelope Proteins That Fuse at Low pH No Longer Require Nef for Optimal Infectivity". Journal of Virology 75, n.º 8 (15 de abril de 2001): 4014–18. http://dx.doi.org/10.1128/jvi.75.8.4014-4018.2001.
Texto completoCopeland, K. M., A. J. Elliot y R. S. Daniels. "Functional Chimeras of Human Immunodeficiency Virus Type 1 gp120 and Influenza A Virus (H3) Hemagglutinin". Journal of Virology 79, n.º 10 (15 de mayo de 2005): 6459–71. http://dx.doi.org/10.1128/jvi.79.10.6459-6471.2005.
Texto completoFeng, Feng, Adam Davis, Julie-Anne Lake, Jill Carr, Wei Xia, Christopher Burrell y Peng Li. "Ring Finger Protein ZIN Interacts with Human Immunodeficiency Virus Type 1 Vif". Journal of Virology 78, n.º 19 (1 de octubre de 2004): 10574–81. http://dx.doi.org/10.1128/jvi.78.19.10574-10581.2004.
Texto completoStevens, Miguel, Christophe Pannecouque, Erik De Clercq y Jan Balzarini. "Novel Human Immunodeficiency Virus (HIV) Inhibitors That Have a Dual Mode of Anti-HIV Action". Antimicrobial Agents and Chemotherapy 47, n.º 10 (octubre de 2003): 3109–16. http://dx.doi.org/10.1128/aac.47.10.3109-3116.2003.
Texto completoEwart, Gary D., Najla Nasr, Hassan Naif, Graeme B. Cox, Anthony L. Cunningham y Peter W. Gage. "Potential New Anti-Human Immunodeficiency Virus Type 1 Compounds Depress Virus Replication in Cultured Human Macrophages". Antimicrobial Agents and Chemotherapy 48, n.º 6 (junio de 2004): 2325–30. http://dx.doi.org/10.1128/aac.48.6.2325-2330.2004.
Texto completoMurakami, Hironobu, Takehiro Suzuki, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Manabu Taura, Eriko Kudo, Seiji Okada et al. "Protein Arginine N-methyltransferases 5 and 7 Promote HIV-1 Production". Viruses 12, n.º 3 (23 de marzo de 2020): 355. http://dx.doi.org/10.3390/v12030355.
Texto completoMete, Bilgül, Emre Pekbilir, Bilge Nur Bilge, Panagiota Georgiadou, Elif Çelik, Tolga Sutlu, Fehmi Tabak y Umut Sahin. "Human immunodeficiency virus type 1 impairs sumoylation". Life Science Alliance 5, n.º 6 (18 de febrero de 2022): e202101103. http://dx.doi.org/10.26508/lsa.202101103.
Texto completoPadow, Marcus, Lilin Lai, Champion Deivanayagam, Lawrence J. DeLucas, Robert B. Weiss, Diane M. Dunn, Xiaoyun Wu y John C. Kappes. "Replication of Chimeric Human Immunodeficiency Virus Type 1 (HIV-1) Containing HIV-2 Integrase (IN): Naturally Selected Mutations in IN Augment DNA Synthesis". Journal of Virology 77, n.º 20 (15 de octubre de 2003): 11050–59. http://dx.doi.org/10.1128/jvi.77.20.11050-11059.2003.
Texto completoZhou, Jing y Christopher Aiken. "Nef Enhances Human Immunodeficiency Virus Type 1 Infectivity Resulting from Intervirion Fusion: Evidence Supporting a Role for Nef at the Virion Envelope". Journal of Virology 75, n.º 13 (1 de julio de 2001): 5851–59. http://dx.doi.org/10.1128/jvi.75.13.5851-5859.2001.
Texto completoMcLinden, James H., Jack T. Stapleton, Donna Klinzman, Krishna K. Murthy, Qing Chang, Thomas M. Kaufman, Nirjal Bhattarai y Jinhua Xiang. "Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4+ T-cells". Journal of General Virology 94, n.º 4 (1 de abril de 2013): 774–82. http://dx.doi.org/10.1099/vir.0.047126-0.
Texto completoAli, Amjad, Rameez Raja, Sabihur Rahman Farooqui, Shaista Ahmad y Akhil C. Banerjea. "USP7 deubiquitinase controls HIV-1 production by stabilizing Tat protein". Biochemical Journal 474, n.º 10 (4 de mayo de 2017): 1653–68. http://dx.doi.org/10.1042/bcj20160304.
Texto completoEspert, Lucile, Geneviève Degols, Yea-Lih Lin, Thierry Vincent, Monsef Benkirane y Nadir Mechti. "Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1". Journal of General Virology 86, n.º 8 (1 de agosto de 2005): 2221–29. http://dx.doi.org/10.1099/vir.0.81074-0.
Texto completoAgrawal, Lokesh, Qingwen Jin, Jeff Altenburg, L. Meyer, R. Tubiana, Ioannis Theodorou y Ghalib Alkhatib. "CCR5Δ32 Protein Expression and Stability Are Critical for Resistance to Human Immunodeficiency Virus Type 1 In Vivo". Journal of Virology 81, n.º 15 (23 de mayo de 2007): 8041–49. http://dx.doi.org/10.1128/jvi.00068-07.
Texto completoKotov, Alexander, Jing Zhou, Paula Flicker y Christopher Aiken. "Association of Nef with the Human Immunodeficiency Virus Type 1 Core". Journal of Virology 73, n.º 10 (1 de octubre de 1999): 8824–30. http://dx.doi.org/10.1128/jvi.73.10.8824-8830.1999.
Texto completoMcGettigan, James P., Satyam Sarma, Jan M. Orenstein, Roger J. Pomerantz y Matthias J. Schnell. "Expression and Immunogenicity of Human Immunodeficiency Virus Type 1 Gag Expressed by a Replication-Competent Rhabdovirus-Based Vaccine Vector". Journal of Virology 75, n.º 18 (15 de septiembre de 2001): 8724–32. http://dx.doi.org/10.1128/jvi.75.18.8724-8732.2001.
Texto completoGordón-Alonso, Mónica, Vera Rocha-Perugini, Susana Álvarez, Olga Moreno-Gonzalo, Ángeles Ursa, Soraya López-Martín, Nuria Izquierdo-Useros et al. "The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry". Molecular Biology of the Cell 23, n.º 12 (15 de junio de 2012): 2253–63. http://dx.doi.org/10.1091/mbc.e11-12-1003.
Texto completoYu, Jae-Sung, James W. Peacock, Stacie Vanleeuwen, Tsungda Hsu, William R. Jacobs, Mark J. Cayabyab, Norman L. Letvin et al. "Generation of Mucosal Anti-Human Immunodeficiency Virus Type 1 T-Cell Responses by Recombinant Mycobacterium smegmatis▿". Clinical and Vaccine Immunology 13, n.º 11 (30 de agosto de 2006): 1204–11. http://dx.doi.org/10.1128/cvi.00195-06.
Texto completoSakalian, Michael, Stephanie S. Dittmer, A. Dustin Gandy, Nathan D. Rapp, Aleš Zábranský y Eric Hunter. "The Mason-Pfizer Monkey Virus Internal Scaffold Domain Enables In Vitro Assembly of Human Immunodeficiency Virus Type 1 Gag". Journal of Virology 76, n.º 21 (1 de noviembre de 2002): 10811–20. http://dx.doi.org/10.1128/jvi.76.21.10811-10820.2002.
Texto completoContarino, Mark, Arangassery R. Bastian, Ramalingam Venkat Kalyana Sundaram, Karyn McFadden, Caitlin Duffy, Vamshi Gangupomu, Michelle Baker, Cameron Abrams y Irwin Chaiken. "Chimeric Cyanovirin-MPER Recombinantly Engineered Proteins Cause Cell-Free Virolysis of HIV-1". Antimicrobial Agents and Chemotherapy 57, n.º 10 (15 de julio de 2013): 4743–50. http://dx.doi.org/10.1128/aac.00309-13.
Texto completoHatanaka, Hideki, Oleg Iourin, Zihe Rao, Elizabeth Fry, Alan Kingsman y David I. Stuart. "Structure of Equine Infectious Anemia Virus Matrix Protein". Journal of Virology 76, n.º 4 (15 de febrero de 2002): 1876–83. http://dx.doi.org/10.1128/jvi.76.4.1876-1883.2002.
Texto completoSoper, Andrew, Guillermo Juarez-Fernandez, Hirofumi Aso, Miyu Moriwaki, Eri Yamada, Yusuke Nakano, Yoshio Koyanagi y Kei Sato. "Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication". Experimental Biology and Medicine 242, n.º 8 (28 de febrero de 2017): 850–58. http://dx.doi.org/10.1177/1535370217697384.
Texto completoTuffy, Kevin M., Rebecca J. Kaddis Maldonado, Jordan Chang, Paul Rosenfeld, Alan Cochrane y Leslie J. Parent. "HIV-1 Gag Forms Ribonucleoprotein Complexes with Unspliced Viral RNA at Transcription Sites". Viruses 12, n.º 11 (9 de noviembre de 2020): 1281. http://dx.doi.org/10.3390/v12111281.
Texto completoKomano, Jun, Kosuke Miyauchi, Zene Matsuda y Naoki Yamamoto. "Inhibiting the Arp2/3 Complex Limits Infection of Both Intracellular Mature Vaccinia Virus and Primate Lentiviruses". Molecular Biology of the Cell 15, n.º 12 (diciembre de 2004): 5197–207. http://dx.doi.org/10.1091/mbc.e04-04-0279.
Texto completoGurer, Cagan, Lionel Berthoux y Jeremy Luban. "Covalent Modification of Human Immunodeficiency Virus Type 1 p6 by SUMO-1". Journal of Virology 79, n.º 2 (15 de enero de 2005): 910–17. http://dx.doi.org/10.1128/jvi.79.2.910-917.2005.
Texto completoWong, G. H., J. F. Krowka, D. P. Stites y D. V. Goeddel. "In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma." Journal of Immunology 140, n.º 1 (1 de enero de 1988): 120–24. http://dx.doi.org/10.4049/jimmunol.140.1.120.
Texto completoMcGettigan, James P., Heather D. Foley, Igor M. Belyakov, Jay A. Berzofsky, Roger J. Pomerantz y Matthias J. Schnell. "Rabies Virus-Based Vectors Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Protein Induce a Strong, Cross-Reactive Cytotoxic T-Lymphocyte Response against Envelope Proteins from Different HIV-1 Isolates". Journal of Virology 75, n.º 9 (1 de mayo de 2001): 4430–34. http://dx.doi.org/10.1128/jvi.75.9.4430-4434.2001.
Texto completoZhou, Yongdong, Liwei Rong, Jennifer Lu, Qinghua Pan y Chen Liang. "Insulin-Like Growth Factor II mRNA Binding Protein 1 Associates with Gag Protein of Human Immunodeficiency Virus Type 1, and Its Overexpression Affects Virus Assembly". Journal of Virology 82, n.º 12 (2 de abril de 2008): 5683–92. http://dx.doi.org/10.1128/jvi.00189-08.
Texto completoOjo-Amaize, E. A., P. Nishanian, D. E. Keith, R. L. Houghton, D. F. Heitjan, J. L. Fahey y J. V. Giorgi. "Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells." Journal of Immunology 139, n.º 7 (1 de octubre de 1987): 2458–63. http://dx.doi.org/10.4049/jimmunol.139.7.2458.
Texto completoClerzius, Guerline, Jean-François Gélinas, Aïcha Daher, Marion Bonnet, Eliane F. Meurs y Anne Gatignol. "ADAR1 Interacts with PKR during Human Immunodeficiency Virus Infection of Lymphocytes and Contributes to Viral Replication". Journal of Virology 83, n.º 19 (15 de julio de 2009): 10119–28. http://dx.doi.org/10.1128/jvi.02457-08.
Texto completoKrishnan, Lavanya, Kenneth A. Matreyek, Ilker Oztop, Kyeongeun Lee, Christopher H. Tipper, Xiang Li, Mohd J. Dar, Vineet N. KewalRamani y Alan Engelman. "The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) during Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase". Journal of Virology 84, n.º 1 (21 de octubre de 2009): 397–406. http://dx.doi.org/10.1128/jvi.01899-09.
Texto completoPontzer, C. H., J. K. Yamamoto, F. W. Bazer, T. L. Ott y H. M. Johnson. "Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau." Journal of Immunology 158, n.º 9 (1 de mayo de 1997): 4351–57. http://dx.doi.org/10.4049/jimmunol.158.9.4351.
Texto completoBennett, Erin M., Andrew M. L. Lever y Jane F. Allen. "Human Immunodeficiency Virus Type 2 Gag Interacts Specifically with PRP4, a Serine-Threonine Kinase, and Inhibits Phosphorylation of Splicing Factor SF2". Journal of Virology 78, n.º 20 (15 de octubre de 2004): 11303–12. http://dx.doi.org/10.1128/jvi.78.20.11303-11312.2004.
Texto completoParveen, Zahida, Muhammad Mukhtar, Adrienne Goodrich, Edward Acheampong, Ralph Dornburg y Roger J. Pomerantz. "Cross-Packaging of Human Immunodeficiency Virus Type 1 Vector RNA by Spleen Necrosis Virus Proteins: Construction of a New Generation of Spleen Necrosis Virus-Derived Retroviral Vectors". Journal of Virology 78, n.º 12 (15 de junio de 2004): 6480–88. http://dx.doi.org/10.1128/jvi.78.12.6480-6488.2004.
Texto completo